Results obtained in our murine model are consistent with data from patients with complete IFN-γR1 deficiency undergoing HSCT [12–15] and demonstrate that susceptibility to BCG, and by extension to other mycobacteria, is a haematopoietic disease in persons with IFN-γR1 deficiency. This evidence concerns the gene IFNGR1 and hematologic disorder.